Filling the need for trusted information on national health issues
In this June 2018 post for The JAMA Forum, Larry Levitt examines the potential impact of the Trump Administration’s legal challenge to the Affordable Care Act’s protections for people with pre-existing conditions.
In this June 2018 post for The JAMA Forum, Larry Levitt examines the potential impact of the Trump Administration’s legal challenge to the Affordable Care Act’s protections for people with pre-existing conditions.
In this March 2018 post for The JAMA Forum, Larry Levitt unpacks the elements of a single payer health plan to understand its policy aims and how they might be accomplished, as well its political opportunities and vulnerabilities.
In this November 2017 post for The JAMA Forum, Larry Levitt reviews the status of the Affordable Care Act following actions by the Trump administration widely perceived as designed to undermine the marketplaces. Despite assertions to the contrary, Levitt finds, “at least for now, the ACA seems very much alive.”
With the effort to repeal or replace the Affordable Care Act seemingly on hold or even dead, Larry Levitt discusses what the Trump administration could do to make the ACA successful – including providing clarity around individual mandate enforcement and cost-sharing reduction payments; maintaining outreach and consumer assistance; and encouraging insurers to participate in the individual insurance marketplaces. The post is now available at The JAMA Forum.
This Visualizing Health Policy infographic looks at costs and outcomes of mental health and substance use disorders in the United States (US).
This Visualizing Health Policy infographic looks at costs and outcomes of mental health and substance use disorders in the United States (US). Nearly 18% of adults reported having a mental, behavioral, or emotional disorder in 2015, including more than 1 in 5 women. Furthermore, nearly 3% of people aged 12…
In this April 2017 post, Larry Levitt discusses the current status of the Affordable Care Act’s health insurance marketplaces, and explains how the Trump administration’s choices — including whether to continue cost-sharing reduction payments to insurers — could influence stability of the marketplaces going forward. The post is now available at The JAMA Forum.
